Research Article
MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis
Table 2
Multiple linear regression models for patients with SCLE.
| | Model | miRNAs | | square | | | Sig. () | 95% IC for | Lower | Up |
| Peripheral cells | | | | | | | | | | CD3+/CD4+/CD25-/IL-4+ | 1 | miR-23b | 0.493 | 0.244 | -0.493 | -2.407 | 0.027 | -0.901 | -0.061 | CD3+/CD4+/CD25+/IFN-γ+ | 1 | miR-1246 | 0.431 | 0.186 | -0.431 | -2.908 | 0.006 | -0.399 | -0.071 | CD3+/CD4+/CD25hi/Foxp3+ | 1 | miR-23b | 0.449 | 0.201 | -0.449 | -2.13 | 0.047 | -1.47 | -0.01 | Tissue cells | | | | | | | | | | IL-4-expressing CD4+ cells (epidermis) | 1 | miR-21 | 0.487 | 0.237 | 0.487 | 2.365 | 0.029 | 0.425 | 7.171 | IFN-γ-expressing CD4+ cells (dermis) | 1 | miR-31 | 0.467 | 0.218 | 0.467 | 2.238 | 0.038 | 0.717 | 22.62 | IL-10-expressing CD20+ cells (epidermis) | 1 | miR-21 | 0.492 | 0.242 | 0.492 | 2.396 | 0.028 | 0.61 | 9.298 |
|
|
SCLE: subacute cutaneous lupus erythematosus; DLE: discoid lupus erythematosus; HD: healthy donors.
|